Increasing Muscle Mass in the Elderly

#559

It’s possible.

1 Like
#560

Great find. The mechanism is called “gravitostat.”

I had a bit of trouble finding it initially as apparently Gravistat is an oral contraceptive pill, lol!

#561

It’s Dumb, But It Builds Muscle Almost 4x Faster

I. Executive Summary

In this investigation presented by Jeremy Ethier, a 30-day intra-individual human trial was conducted to evaluate the hypertrophic and neuromuscular impacts of daily resistance training (7 days per week) compared to standard training frequency (2 days per week). To isolate local muscular adaptation from inter-individual genetic variability, three subjects trained one side of their body daily (accumulating 35 hard sets per week) while training the contralateral control side twice weekly (accumulating 10 hard sets per week). Muscle cross-sectional area was quantified using baseline and 30-day post-intervention magnetic resonance imaging (MRI) scans, preceded by a mandatory 72-hour training washout to eliminate transient muscle swelling and edema.

All three participants demonstrated superior hypertrophy and local strength endurance gains on the daily-trained limb. In trained subjects, arm muscle volume increased by 3 percent on the daily side versus 1 percent on the control side, while quadriceps/hamstring volume expanded by 2 to 3 percent versus 0 percent. In a less experienced lifter, chest hypertrophy reached 19.6 percent on the daily side compared to 5.0 percent on the control side. Mechanistically, two core physiological phenomena explain these outcomes:

  1. Dissociation of Soreness and Recovery: Delayed Onset Muscle Soreness (DOMS) peak intensity does not track neuromuscular force deficits. Force production capability returns to baseline well before subjective soreness resolves.
  2. The Repeated Bout Effect (RBE): High-frequency mechanical tension rapidly upregulates structural remodeling and neural protective mechanisms, suppressing microtrauma and eliminating DOMS within 7 to 10 days of continuous exposure (ResearchGate, 1998).

However, a primary methodological limitation of this trial is the confounding of training frequency with total weekly set volume (35 sets versus 10 sets per week). Systematic meta-analyses demonstrate that muscle hypertrophy is primarily dictated by total volume rather than frequency when volume is equated (Schoenfeld et al., 2017). Furthermore, unrotated daily heavy loading presents high connective tissue overuse risks; tendons and ligaments adapt far slower than vascularized skeletal muscle. Daily training is an unsustainable long-term strategy, but its biological principles can be safely applied via periodic, short-term “specialization cycles” using systematic exercise rotation.

II. Insight Bullets

  1. Intra-Individual Trial Design: Utilizing a within-subject model (training the right side daily and the left side twice weekly) eliminates genetic, dietary, hormonal, and sleep-related confounding variables across experimental arms.
  2. MRI Gold-Standard Measurement: Muscle cross-sectional area was evaluated via 3D MRI scans analyzed blindly by exercise science researchers, providing high sensitivity for detecting subtle short-term hypertrophic changes.
  3. Edema Washout Protocol: Requiring a 72-hour rest window prior to post-intervention MRI scans prevents transient muscular fluid accumulation (edema) from skewing hyperplastic or hypertrophic volume data.
  4. Volume-Frequency Confounding: The daily training arm performed 35 hard sets per week compared to 10 sets on the control arm, meaning the observed hypertrophy was primarily driven by a 3.5-fold volume increase rather than frequency in isolation.
  5. Dose-Response Hypertrophy Relationship: Systematic meta-analyses confirm a clear dose-response relationship between weekly set volume and muscle growth, provided sets are executed at sufficient proximity to failure (PMC, 2018).
  6. Soreness Is Not a Marker of Muscle Damage: Delayed Onset Muscle Soreness (DOMS) reaches peak intensity approximately 24 to 48 hours post-exercise, a time point when neuromuscular force production has frequently returned to baseline.
  7. Force Recovery Outpaces DOMS Resolution: Training a muscle while subjectively sore does not impair performance or interrupt hypertrophic signaling if motor unit force generation has fully recovered.
  8. The Repeated Bout Effect (RBE): Repetitive exposure to muscle-damaging eccentric contractions induces rapid neural, connective tissue, and cellular structural adaptations that protect muscle fibers from subsequent damage (Frontiers, 2021).
  9. Attenuation of DOMS Timeline: Subjective muscle soreness completely disappeared within 7 to 8 days of daily training due to the Repeated Bout Effect rapidly downregulating inflammatory signaling.
  10. Training Status Modulates Hypertrophic Speed: Highly trained lifters exhibited modest 30-day growth (2 to 3 percent), whereas a less experienced lifter achieved massive growth (19.6 percent), reflecting the progressive attenuation of hypertrophic potential over time.
  11. Differential Adaptation Rates: Skeletal muscle tissue possesses high vascularity and adapts rapidly to daily stress, whereas tendons and articular cartilage adapt slowly due to poor blood flow.
  12. Connective Tissue Overuse Risk: High-frequency training using fixed exercise patterns drastically increases the risk of tendinopathy and joint impairment, even when muscle tissue successfully adapts.
  13. Exercise Rotation as Joint Protection: Rotating 2 to 3 distinct exercise variations for a single muscle group alters joint force vectors and distributes mechanical stress, preventing focal tendon microtrauma.
  14. Daily Training Strength Adaptations: All participants exhibited greater rep capacity and neural skill execution on their daily-trained limb, driven by frequent motor pattern rehearsal.
  15. Per-Session Volume Density Thresholds: Attempting to perform 30+ sets per muscle group in a single workout causes rapid set-quality degradation; distributing volume across multiple days maintains high mechanical tension per set.
  16. Chest Hypertrophy Outcomes: The less experienced subject achieved a 19.6 percent cross-sectional increase in chest muscle on the daily side (35 sets/week) versus 5.0 percent on the control side (10 sets/week).
  17. Arm Hypertrophy Outcomes: Biceps and triceps cross-sectional area increased by 3 percent on the daily arm compared to 1 percent on the twice-weekly control arm.
  18. Leg Hypertrophy Outcomes: Experienced leg training yielded a 2 to 3 percent increase in quadriceps volume on the daily leg compared to 0 percent on the control leg.
  19. Specialization Cycle Concept: Rather than training the whole body daily, lifters can safely apply high-volume stimulus by prioritizing 1 to 2 lagging muscle groups at the start of standard training sessions.
  20. Exercise Order Prioritization: Placing target specialization exercises at the absolute beginning of a workout maximizes neural drive and mechanical tension before systemic fatigue sets in.
  21. Tendon Strain Incompatibility: Continuous 1RM maxing or unrotated daily heavy loading leads to high injury attrition; a 34-day daily bench press trial noted that over half of participants experienced joint pain despite strength gains (StrengthLog, 2025).
  22. Practical Unsustainability: Daily single-muscle training is time-inefficient, fatigue-intensive, and offers diminishing returns compared to structured, well-recovered split routines.

IV. Actionable Protocol (Prioritized)

High Confidence Tier (Level A/B Evidence)

Protocols backed by systematic reviews, meta-analyses, and well-controlled resistance training RCTs.

  • Weekly Volume Escalation for Hypertrophy:
    • Evidence Level: Level A Meta-Analysis (Schoenfeld et al., 2017).
    • Protocol: Program 10 to 20 hard sets per muscle group per week for optimal hypertrophic progression. Advanced lifters may temporarily push to 20–30 sets per week, provided volume is distributed across 2 to 4 sessions to avoid per-session quality degradation.
  • Frequency Optimization with Volume Equated:
    • Evidence Level: Level A Meta-Analysis (PMC, 2021).
    • Protocol: Train each major muscle group 2 to 3 times per week. When total weekly set volume is matched, training a muscle 2–3 days per week yields comparable muscle growth to higher frequencies without provoking joint overuse.
  • Objective Force-Based Autoregulation:
    • Evidence Level: Level B RCT Evidence (ResearchGate, 1998).
    • Protocol: Do not use subjective soreness (DOMS) as the primary indicator of recovery. If rep performance and force production are maintained at baseline levels, the muscle is biologically prepared for high-intensity mechanical loading regardless of mild residual soreness.

Experimental Tier (Level C/D Evidence)

Protocols derived from short-term intra-individual trials, acute physiological models, and expert consensus.

  • Targeted Muscle “Specialization Cycles”:
    • Evidence Level: Level C Preclinical / Short-Term Trial Data.
    • Protocol: Select a single lagging muscle group (e.g., side deltoids or calves) and perform 2 to 3 hard sets at the start of existing workouts 4 to 6 days per week for 4 to 6 weeks. Cap total specialized volume at 20–30 weekly sets, then return to maintenance volume (6–10 sets/week).
  • Systematic Exercise Rotation for Joint Protection:
    • Evidence Level: Level D Physiological Consensus.
    • Protocol: When training a muscle group with high weekly frequency (3+ days/week), alternate between 2 or 3 distinct exercise variations (e.g., Day A: Incline Dumbbell Press; Day B: Cable Flyes; Day C: Dips) to shift mechanical stress vectors and prevent focal tendon microtrauma.

Red Flag Zone (Safety Data Absent / High Risk)

Unsafe, unvetted, or counterproductive practices lacking long-term clinical safety data.

  • Unrotated Daily Heavy Compound Loading (Daily 1RM or High-Volume Daily Lifts):
    • Status: High Hazard / High Injury Rate.
    • Risk Assessment: Performing heavy compound movements (e.g., max bench press or squats) daily without exercise rotation causes severe tendon degeneration, joint microtrauma, and high injury rates (StrengthLog, 2025).
  • Equating Soreness (DOMS) with Hypertrophic Signaling:
    • Status: Debunked Fallacy.
    • Risk Assessment: Chasing extreme muscle soreness via constant exercise variation impairs force production, prolongs recovery timelines, and lowers total effective weekly training volume.
  • Neglecting Washout Periods in Progress Tracking:
    • Status: Methodological Error.
    • Risk Assessment: Judging muscle growth immediately after high-volume daily training misinterprets acute intracellular fluid accumulation and inflammation (edema) as true structural muscle protein synthesis.

Produced by Gemini 2.0 Flash

5 Likes
#562

Sorry, I don’t plan on going to the gym 7 days a week anytime soon.:face_with_diagonal_mouth:

2 Likes
#563

Will muscle-boosting meds be the next big thing after GLP-1 drugs?

A number of drugs designed to prevent muscle loss and boost muscle growth are being tested in clinical trials. Columnist Michael Le Page looks at whether building and maintaining muscles is about to get a whole lot easier

Essentially, muscle is costly to maintain in energy terms, so we’ve evolved to use it or lose it. In addition to muscle-boosting growth factors released when we use our muscles, there are muscle-shrinking factors like myostatin. The size of our muscles is determined by the balance between them: shift the dial by blocking myostatin and the same level of exercise should result in larger muscles.

That could make a big difference in older age. “You want people to maintain mobility with old age, be it to get up a flight of stairs, go to the bathroom or go to the store,” says David Glass at Regeneron, one of the companies developing muscle-boosting drugs.

“But starting in your 30s, you lose strength as you get older,” he says. “There are naturally occurring mechanisms that make it harder to get a benefit from [exercise].”

Staying mobile is just one benefit of being more muscular. The fact that maintaining big muscles requires a lot of calories is an advantage in a world where many of us eat too much. Boosting muscles should help prevent or treat obesity as well as related conditions such as diabetes.

There is also concern that the long-term use of myostatin-blocking drugs could affect a vital muscle: the heart. But in a study that came out in March, Glass and his colleagues analysed data on a million people in the UK Biobank study. They found no signs of cardiovascular issues in people with mutations affecting myostatin function – but these people did have up to 10 per cent more muscle and a higher grip strength.

Despite the disappointing initial results, pharmaceutical companies have got a lot more interested in developing muscle-boosting drugs thanks to the runaway success of GLP-1 weight-loss drugs. That’s because it turns out that GLP-1 drugs result in a loss of muscle mass as well as fat.

When people stop taking GLP-1 drugs, they often regain lost fat very quickly, say Gabriel. But they don’t regain the muscle as fast. This has led to concern that muscle loss could become a major problem in people who repeatedly start and stop taking these drugs.

So, many of the newer myostatin-targeting drugs are now being tested in combination with GLP-1 drugs. The hope is that they can not only reduce or prevent muscle loss, but also enhance weight loss, because of the extra energy needed to maintain muscle.

The results of one animal trial, published last year, caused much excitement in some corners of the internet. Regeneron gave obese cynomolgus monkeys a triple therapy consisting of the GLP-1 drug semaglutide, a myostatin precursor-targeting antibody called trevogrumab and an activin A-targeting antibody called garetosmab. The monkeys gained lean mass while losing a lot more weight than animals given semaglutide alone. One YouTuber with a large following suggested these drugs would replace steroids for bodybuilders.

But interim results from Regeneron’s phase II trial in humans are less positive. The triple combo did prevent 80 per cent of the lean mass loss seen with semaglutide alone, while boosting fat loss. But a third of these people developed side effects severe enough for them to stop taking the drugs.

Read the full story: Will muscle-boosting meds be the next big thing after GLP-1 drugs? (New Scientist)

Related Threads:

1 Like
#564

Over 65? Stop Muscle Loss NOW By Doing THIS (most skip it)

I. Executive Summary

Sarcopenia—the age-related involuntary loss of skeletal muscle mass, quality, and strength—is driven primarily by anabolic resistance, neuromuscular denervation, and blunted postprandial muscle protein synthesis (MPS). The two primary physiological triggers that govern MPS are mechanical tension derived from resistance exercise and systemic availability of essential amino acids (EAAs), with L-leucine acting as the rate-limiting molecular signal activating mechanistic target of rapamycin complex 1 (mTORC1). The long-standing Recommended Dietary Allowance (RDA) of 0.8 g/kg/day for protein in the United States and Canada represents an epidemiological threshold established to prevent negative nitrogen balance and frank deficiency in sedentary young adults, rather than an optimal target to maintain metabolic homeostasis or support myofibrillar protein accretion in aging populations.

Stable isotope tracer studies conducted by Dr. Stuart Phillips and international consensus panels demonstrate that overcoming age-related anabolic resistance requires an intake of at least 1.2 g/kg/day of high-quality protein in healthy older adults (≥65 years). In individuals combining dietary optimization with progressive resistance training, myofibrillar protein synthesis reaches a therapeutic ceiling at approximately 1.60 to 1.62 g/kg/day, beyond which excess amino acids undergo hepatic transamination, deamination, and urea excretion rather than muscle accretion. To optimize the leucine threshold (~2.5–3.0 g per bolus), dietary protein should be distributed across meals at approximately 0.4 g/kg per meal, with priority placed on morning protein ingestion to align with circadian amino acid transporter kinetics.

Beyond resistance exercise (prescribed at a minimum frequency of two to three sessions weekly) and high-quality dietary protein, adjunct therapies mitigate muscular atrophy. Thermal stress via regular sauna exposure elevates cytoprotective heat shock proteins (e.g., HSP72, HSP27) and transiently stimulates growth hormone secretion, inhibiting proteolytic degradation pathways (ubiquitin-proteasome and autophagy-lysosome). Concurrently, long-chain omega-3 fatty acids (EPA and DHA) incorporate into sarcolemmal phospholipids, sensitizing mTORC1 signaling and attenuating disuse muscle atrophy, while maintaining sufficient 25-hydroxyvitamin D supports genomic muscle calcium handling and prevents type II muscle fiber atrophy.

II. Insight Bullets

  • Skeletal muscle protein synthesis is primarily regulated by two upstream physiological stimuli: mechanical tension from resistance training and circulating essential amino acids.
  • L-leucine functions as the critical nutritional trigger that directly stimulates mechanistic target of rapamycin complex 1 (mTORC1) phosphorylation to initiate translation.
  • The current Recommended Dietary Allowance (RDA) of 0.8 g/kg/day for protein reflects the bare minimum required to avoid negative nitrogen balance rather than an intake that supports optimal metabolic function (Phillips et al., 2016).
  • Stable isotope metabolic tracer methodologies confirm that older adults require higher baseline amino acid availability to overcome age-associated anabolic resistance.
  • An intake of 1.2 g of high-quality protein per kilogram of body weight per day represents the baseline physiological target to support muscle maintenance in older adults (Bauer et al., 2013).
  • When paired with structured resistance training, total daily protein intake saturates myofibrillar protein synthesis benefits at approximately 1.60 to 1.62 g/kg/day (Morton et al., 2018).
  • Increasing protein intake past 1.62 g/kg/day does not yield statistically significant additions to lean mass or handgrip strength in clinical trials (Nunes et al., 2022).
  • Dietary protein is not stored in bodily reserves; amino acids consumed beyond synthetic capacity are oxidized and cleared as urea.
  • A per-meal dosing strategy of approximately 0.4 g of protein per kilogram of body weight optimizes the intracellular leucine threshold across three distinct feeding windows (Moore et al., 2015).
  • While aggregating daily protein into a single large feeding can sustain nitrogen balance, distributing intake evenly maintains a more consistent systemic amino acid flux.
  • Whole-food proteins with high leucine concentrations, such as intact eggs, dairy, poultry, and fish, elicit superior per-gram anabolic responses (Katsanos et al., 2006).
  • Supplemental protein powders, such as whey isolate or egg white protein, serve as pragmatic tools to attain per-meal leucine thresholds without excess caloric burden.
  • Structured resistance training performed two to three days per week provides the minimum effective mechanical stimulus to preserve myofibrillar protein volume (Schoenfeld et al., 2016).
  • Engaging in resistance exercise only once per week is superior to physical inactivity but remains suboptimal for driving skeletal muscle hypertrophy.
  • Elite bodybuilding regimens exceeding four to five training sessions weekly surpass the volume required for routine sarcopenia prevention in older adults.
  • High-temperature sauna bathing induces cellular heat shock proteins (such as HSP72 and HSP27) that mitigate skeletal muscle proteolytic breakdown (Tamura et al., 2014).
  • Whole-body hyperthermia stimulates transient neuroendocrine elevations in endogenous growth hormone that support body composition management (Patrick & Johnson, 2021).
  • Long-chain omega-3 polyunsaturated fatty acids (EPA and DHA) attenuate skeletal muscle disuse atrophy and enhance postprandial muscle protein synthesis (McGlory et al., 2019).
  • Omega-3 supplementation incorporates into the muscle phospholipid membrane, sensitizing anabolic intracellular signaling pathways in response to hyperaminoacidemia (Smith et al., 2011).
  • Vitamin D functions pleiotropically as a secosteroid hormone regulating gene transcription involved in type II muscle fiber recruitment and fall prevention (Bischoff-Ferrari et al., 2004).
  • Skewing protein distribution toward the morning meal improves 24-hour muscle protein accretion and functional strength in older adults (Aoyama et al., 2021; Zheng et al., 2024).
  • Circadian rhythms influence intestinal peptide absorption and peripheral amino acid transport efficiency throughout the diurnal cycle.
  • Nutrient timing relative to the resistance training window exerts a minor effect compared to hitting total daily protein targets.
  • Maintaining skeletal muscle mass is clinically linked to reduced risks of frailty, metabolic dysfunction, accidental falls, and all-cause mortality in the elderly.

IV. Actionable Protocol (Prioritized)

High Confidence Tier (Level A/B Evidence)

Domain Clinical Action Dosing / Target Primary Endpoint
Dietary Protein Intake Increase daily protein intake above the standard RDA to overcome anabolic resistance 1.20–1.60 g/kg/day total high-quality protein (Bauer et al., 2013; Morton et al., 2018) Maximize myofibrillar protein synthesis (MPS) and preserve appendicular lean mass
Mechanical Stimulation Execute structured, progressive resistance training involving major compound movements 2–3 sessions/week; 2–4 sets of 8–15 repetitions per muscle group to near failure (Schoenfeld et al., 2016) Induce mechanotransductive signaling, preserve motor unit recruitment, and enhance muscular force
Per-Meal Distribution Distribute protein intake across 3 balanced boluses, prioritizing morning consumption ~0.40 g/kg per meal, providing ≥2.5–3.0 g of L-leucine per feeding (Moore et al., 2015; Aoyama et al., 2021) Cross the intracellular leucine trigger threshold and optimize circadian amino acid utilization
Vitamin D Repletion Screen serum 25-hydroxyvitamin D and supplement as needed to correct deficiency Target serum 25(OH)D: 30–50 ng/mL (typically 1,000–2,000 IU/day D3) (Bischoff-Ferrari et al., 2004) Support calcium-dependent cross-bridge cycling and prevent type II muscle fiber atrophy

Experimental Tier (Level C/D Evidence - High Safety Margin)

  • Long-Chain Omega-3 Fatty Acid Supplementation: Administer 2.0–4.0 g/day of combined EPA and DHA (providing at least 1.5–2.0 g EPA). Mechanistically, this increases membrane phospholipid fluid dynamics and sensitizes p70S6K1 phosphorylation, protecting against disuse atrophy during sedentary intervals or immobilization (McGlory et al., 2019). Monitor bleeding risk if co-administered with anticoagulants.
  • Passive Whole-Body Hyperthermia (Finnish Sauna): Complete 2 to 3 sessions per week of traditional sauna exposure at 160–185 °F (70–85 °C) for 15–20 minutes. This induces cellular expression of heat shock proteins (HSP72 and HSP27) to inhibit the forkhead box O (FoxO) and ubiquitin-proteasome atrophy pathways while transiently elevating growth hormone (Patrick & Johnson, 2021). Maintain adequate oral fluid and electrolyte replenishment; monitor for orthostatic hypotension.
  • Targeted Leucine-Enriched Whey/Egg Protein Boluses: Ingest 20–30 g of rapidly digested protein isolate containing 2.5–3.0 g of intact leucine within 60 minutes of waking. This compensates for reduced splanchnic extraction and blunted microvascular perfusion common in older adults. Monitor fasting blood glucose and renal parameters during routine annual physicals.

Red Flag Zone (Debunked, High-Risk, or Contraindicated)

Restricting Dietary Protein to the RDA (0.8 g/kg/day) in Adults Over 65: Adhering strictly to 0.8 g/kg/day in older populations precipitates progressive, silent skeletal muscle atrophy. The RDA was mathematically modeled to prevent frank nitrogen deficiency in young cohorts; in older adults suffering from age-related anabolic resistance, this intake fails to support net positive protein balance and accelerates sarcopenia and functional decline.

Escalating Protein Intakes Above 2.0 g/kg/day for Hypertrophic Superiority: Ingesting extreme protein intakes (>2.0 g/kg/day) under the misconception that it will linearly amplify muscle mass. Systematic meta-analyses confirm that muscle protein synthesis reaches a plateaud ceiling at ~1.62 g/kg/day; amounts beyond this threshold are diverted to amino acid oxidation and hepatic urea cycle load rather than myofibrillar protein synthesis.

Sauna Exposure in Uncontrolled Cardiovascular Instability: Utilizing high-heat Finnish sauna bathing in patients with uncorrected severe aortic stenosis, recent acute myocardial infarction (<3 months), or unstable cardiac arrhythmias. The intense peripheral vasodilation and compensatory tachycardia create hemodynamic shear stress that is strictly contraindicated in uncompensated heart disease.

For an examination of the cellular and physiological mechanisms through which thermal stress counters muscle wasting, review Sauna Use and Heat for Strength Preservation.

This presentation provides a clear overview of the molecular pathways, heat shock protein dynamics, and clinical considerations supporting sauna use to prevent muscle atrophy.

Produced by Gemini 2.5 Flash